- Case report
- Open Access
Mixed germ cell tumor metastatic to the skin: Case report and literature review
© Chuang et al; licensee BioMed Central Ltd. 2010
- Received: 4 January 2010
- Accepted: 23 March 2010
- Published: 23 March 2010
Testicular cancer is the most common cancer for males aged 15~35 years old. The initial presentation is typically an asymptomatic enlarged testicle. The retroperitoneum is the most common metastatic area. Other metastatic sites include the lung, liver, brain, adrenal glands, gastrointestinal tract and spleen. Skin metastasis is a rare event and frequently associated with poor prognosis.
A 19-year old male was diagnosed testicular mixed germ cell tumor with initial presentation of cutaneous metastasis at scalp and upper abdomen. After radical orchiectomy and four courses of cisplatin-based chemotherapy, the scalp and upper abdominal lesions regressed completely. The size of lung metastases remained unchanged.
For advanced stage testicular cancer, cisplatin-based chemotherapy is still effective to achieve partial response.
- Germ Cell Tumor
- Testicular Cancer
- Testicular Germ Cell Tumor
- Cutaneous Metastasis
Cutaneous manifestation of an internal malignancy is rare, with an incidence of 2.9-9%[1, 2]. The frequencies of skin metastases in females are 69% for breast cancer, 9% for colon cancer, and 5% for melanoma. In males the frequencies of cutaneous metastases are 24% for lung cancer, 19% for colon cancer, and 13% for melanoma [3, 4] Cutaneous metastases of the genitourinary tract tumors have been associated with cancers of the prostate , bladder , and kidney . This report describes a case of testicular germ cell tumor with skin metastases at the initial presentation.
Cutaneous metastases originating from a solid organ are roughly 2% . Most of the cutaneous metastases were noted by a prior cance diagnosis; While only 8% of cases represented the first indication of an internal malignancy . The most common sites of metastastatic disease from urologic malignancies are lymph nodes, bone, lung, and liver . The incidence of cutaneous metastasis from all urologic malignancies is 1.1% to 2.5% . The relative incidences of metastasis to the skin among gentitourinary cancers are 3.4% to 4.0% for renal cell carcinoma, 0.84% to 3.6% for transitional cell carcinoma, 0.4% for germ cell tumors, and 0.36% to 0.7% for prostate adenocarcinoma.
Testicular mixed germ cell tumors are common, comprising roughly 33% of all testicular tumors. The reason for such a high incidence of testicular mixed germ-cell tumors is because germ cells in the testes are totipotent and can undergo either trophoblast or somatic differentiation. Among all the subtypes of testicular germ cell tumor, choriocarcinoma is the most aggressive with highly metastatic potential .
The cutaneous metastasis as the first sign of metastatic choriocarcinoma could have been either an occult or a slow growing primary testis germ cell tumor [11–15]. Cutaneous metastasis of the genitourinary malignant neoplasm is often related to advanced local extension, disseminated metastasis and poor prognosis. In this case, no retroperitoneal lymph node metastasis was observed.
According to the International Germ Cell Consensus Prognosis for Testicular Cancer, the 5-year progression-free survival rate is 41% for non-seminoma origin and non-pulmonary visceral metastasis. The present case was classified as poor prognostic. After four courses of PEB regimen (cisplatin, etoposide, bleomycin), the scalp and abdominal lesions achieved complete response but the lung metastasis remained stable in size.
The skin is an uncommon site for testicular germ cell metastasis. A cutaneous lesion can be difficult to be differentiated from a primary cutaneous neoplasm. Excisional biopsy is required for definite diagnosis. For advanced stage testicular cancer, cisplatin-based chemotherapy is still effective to achieve biochemical remission.
Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
- Spencer PS, Helm TN: Skin metastases in cancer patients. Cutis. 1987, 39: 119-21.PubMedGoogle Scholar
- Mueler TJ, Wu H, Geenberg RE, Hudes G, Topham N, Lessin SR, Uzzo RG: Cutaneous metastases from genitourinary malignancies. Urology. 2004, 63: 1021-6. 10.1016/j.urology.2004.01.014.View ArticleGoogle Scholar
- Healy P, Malott K, Chalet M: Cancers metastatic to the skin. Cancer of the skin. Edited by: Friedman RJ, Rigel DS, Kopf AW, Harris MN, Baker D. 1991, Philadelphia: W.B. Saunders, 347-64.Google Scholar
- Brash DE: Cancer of the skin. Cancer: Principles and practice of oncology. Edited by: DeVita VT, Rosenberg, SA, Hellman S. 1997, Philadelphia: Lippincott-Raven, 1913-50. 5Google Scholar
- Aria K, Kawashima T, Shimizu H: Cutaneous metastasis of prostate carcinoma. Clin Exp Dermatol. 2002, 27: 64-5. 10.1046/j.0307-6938.2001.00966.x.View ArticleGoogle Scholar
- Akman Y, Cam K, Kavak A, Alper M: Extensive cutaneous metastasis of transitional cell carcinoma of the bladder. Int J Urol. 2003, 10: 103-104. 10.1046/j.1442-2042.2003.00571.x.View ArticlePubMedGoogle Scholar
- Gurer CK, Karaduman A, Bukulmez G, Sahin S, Ozkaya O, Erkan I: Renal cell carcinoma with skin metastasis. J Eur Acad Dermatol Venereol. 2004, 18: 386-7. 10.1111/j.1468-3083.2004.00903.x.View ArticlePubMedGoogle Scholar
- Saeed S, Keehn CA, Morgan MB: Cutaneous metatasis: a clinical, pathological and immunohistochemical appraisal. J Cutan Pathol. 2004, 31: 419-30. 10.1111/j.0303-6987.2004.00207.x.View ArticlePubMedGoogle Scholar
- Block CA, Dahmoush L, Konety BR: Cutaneous metatases from transitional cell carcinoma of the bladder. JUrol. 2006, 67 (846): e15-7.Google Scholar
- Tinkle LL, Graham BS, Spillane TJ, Barr RJ: Testicular choriocarcinoma metastatic to the skin: an additional case and literature review. Cutis. 2001, 67: 117-20.PubMedGoogle Scholar
- Kiriyama T, Yoshida O: A review of the cases of testicular tumors reported in the annual of pathological autopsy cases in Japan. Hinyokika Kiyo. 1983, 29: 155-68.PubMedGoogle Scholar
- Bredael JJ, Vugrin D, Whitmore WF: Autopsy findings in 154 patients with germ cell tumors of the testis. Cancer. 1982, 50: 548-51. 10.1002/1097-0142(19820801)50:3<548::AID-CNCR2820500327>3.0.CO;2-2.View ArticlePubMedGoogle Scholar
- Figurin KM: Effect of retroperitoneal lymphadenectomy on late therapeutic results in testicular tumors. Vopr Onkol. 1981, 27: 70-3.PubMedGoogle Scholar
- Wettlaufer JN: Stage III germinal testis tumors: aggressive approach. J Urol. 1976, 116: 593-7.PubMedGoogle Scholar
- Xinhua Chen, Linjie Xu, Xinmei Chen, Xiaodong Teng, Shusen Zheng: Testicular choriocarcinoma metastatic to skin and multiple organs. Two case reports and review of literature. J Cutan Pathol. 2009, 37 (4): 486-90.Google Scholar
- International Germ Cell Consensus Classification: A prognostic factor based staging system for metastatic germ cell cancers. J Clin Oncol. 1997, 15: 594-603.Google Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.